Noramco™ Email Format

Pharmaceutical ManufacturingDelaware, United States51-200 Employees

Noramco is a pharmaceutical manufacturing company headquartered in Wilmington, Delaware, with a global footprint that includes Athens, Georgia and Neuhausen, Switzerland, and a workforce of roughly 201 to 500 employees. It develops and manufactures controlled substances for pharmaceutical applications, including medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and formulations designed to deter abuse. The company focuses on high-purity controlled substances, leveraging intellectual property to create efficient routes to APIs, and provides analytical data, chemical and physical properties, stability studies, and regulatory assistance. It offers formulation-friendly particle size grades and extended technical packages, along with DEA-compliant security and production capacity spanning from kilos to multi-ton quantities, supporting supply security from schedule I to schedule III. In April 2026, Siegfried Ltd announced the acquisition of Noramco Inc, with around 400 employees expected to join Siegfried.

Get verified Noramco™ emails free

Company overview Employee directory